Ovid Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
0.1595 | 57.27 | -99.72% | -1.57 | -110.19% |
| P/S |
|
618.06 | 33.44 | 1748.53% |
|
|
| P/BV |
|
2.76 | 4.64 | -40.61% |
|
|
| P/FCF |
|
-5.96 | 42.53 | -114.02% |
|
|
| Ev/Ebitda |
|
-4.53 | -17.68 | -74.4% |
|
|
| Ev/S |
|
666.47 | 22.59 | 2849.7% |
|
|
| Ev/FCF |
|
-5.69 | 47.55 | -111.96% |
|
|
| E/P |
|
-0.1911 | 0.0182 | -1150% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-14726.99 | -14.2 | 103583.85% | -6728.86 | +118.86% |
| ROE |
|
-59.61 | 9.78 | -709.38% |
|
|
| ROA |
|
-36.34 | 0.33 | -11110.42% |
|
|
| ROIC |
|
-31.03 | 7.63 | -506.45% |
|
|
| ROS |
|
-13362.17 | -26.41 | 50487.97% |
|
|
| ROCE |
|
-67.52 | 14.5 | -565.6% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.7975 | -3.87 | -79.41% | -0.5444 | +46.49% |
| Nеt Debt/Ebitda |
|
-0.3287 | -4.24 | -92.25% |
|
|
| Debt/Ratio |
|
0.3194 | 0.1853 | 72.37% |
|
|
| Debt/Equity |
|
41.82 | 1.56 | 2575.56% |
|
|
| Debt/Net Income |
|
-0.8789 | 10.06 | -108.74% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-96.89 | 30.62 | -416.43% | ||
| Growth impulse Ebitda in 5 years |
|
-6.05 | -17.42 | -65.27% | ||
| Growth impulse Net Income in 5 years |
|
-11.74 | -52.26 | -77.54% | ||
| Growth impulse FCF in 5 years |
|
-10.49 | -31.68 | -66.89% | ||
| Growth impulse EPS in 5 years |
|
-50.89 | -61.82 | -17.68% |
IP Score
2.5/10
